Michael Schickler
Head of Clinical & Regulatory AffairsDr. Michael Schickler, Ph.D. serves as Head of Clinical and Regulatory Affairs for Purple Biotech Ltd. since 2022. He served as Head of Regulatory and Clinical Operations at Purple Biotech Ltd. since January 2020 until 2022. Dr. Schickler served as the Chief Executive Officer of CureTech Ltd. since May 2001. Dr. Schickler was Head of Clinical Operations at Purple Biotech Ltd. (formerly known as Kitov Pharma Ltd) since January 2020. Dr. Schickler joined CureTech in May 2001. Dr. Schickler played a key role in transforming it from a virtual, university-based, entity into an independent company. He has over 18 years of profound managerial and technological experience in the biopharmaceutical industry. Dr. Schickler also served as Managing Director of Clal Life Sciences L.P., the research center of Clal Biotechnology Industries in Israel, which he also helped to establish. Prior to that, Dr. Schickler served as Vice President, Development of Pharmos Corp. and Managing Director of Pharmos Ltd. Prior to joining Pharmos, Dr. Schickler held research positions with Hoffmann-La Roche Inc. He also held an academic position with the Volcani Institute, Israel. Dr. Schickler serves as Chairman of Mindset BioPharmaceuticals Ltd. and Co-Chairman of Israel Biotechnology Organization. He served as a Director of MediWound Ltd. Dr. Schickler earned his Ph.D. in Biology from the Weizmann Institute of Science, has an MSc. in immunology from the Tel-Aviv University, and holds a diploma in Business Administration from the Lincoln University, UK. Dr. Schickler received B.Sc. in Biology from The Faculty of Life Sciences, Tel-Aviv University, Israel.
Positions
- Company NamePurple Biotech LtdStock CodePPBTPositionHead of Clinical & Regulatory Affairs
